• Question 2
0 out of 1 points The PMHNP is meeting with a new mother who would like to begin taking medication again to treat her bipolar depression;
... [Show More] she is breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this patient?
Selected Answer:
C.
Lithium (Lithobid)
• Question 3
Mr. Gordon is a middle-aged client who was started on
1 out of 1 points
antidepressant monotherapy for depression. After beginning this medication, the PMHNP noticed that this client seemed to swing into a hypomanic episode. What can the PMHNP infer from this behavior change?
Selected Answer:
A.
This client may have Bipolar III disorder
• Question 4
1 out of 1 points
A patient presents with frequent episodes of mania. Which statement describes an appropriate treatment approach for this patient?
Selected Answer:
B.
“The patient could benefit from an
anticonvulsant.”
• Question 5
1 out of 1 points
The student inquires about antipsychotic medications. Which response by the PMHNP describes the factors that contribute to reduced risk of extrapyramidal symptoms (EPS) for patients who take antipsychotics?
Selected Answer:
B.
Those that are potent D2 antagonists with 5HT2A antagonism properties
• Question 6
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for which possible effect?
Selected Answer:
D.
All of the above
• Question 7
1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics heard the psychiatrist tell the patient that the patient would be placed on a different antipsychotic agent called an atypical antipsychotic. What neurotransmitters will this new medication work on?
Selected Answer:
A.
dopamine and serotonin
• Question 8
1 out of 1 points
While genes have potential to modify behavior, behavior can also modify genes. How do genes impact this process?Selected Answer:B.
Changes made to proteins lead to changes in behavior.
• Question 9
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no established history of depression. When meeting with the PMHNP, she presents with apathy and withdrawn social behavior, and she reports a loss of joy from enjoyable activities since starting her new medication. What does
the PMHNP infer from this encounter with the client?
Selected Answer:
C.
The new medication is blocking D2 receptors in the mesolimbic system [Show Less]